£495.00

The 2023-2028 Outlook for Benzodiazepine Drugs in Japan

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 83 days · 83 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 11 June 2026 01 July 2026 22 July 2026 11 August 2026 01 September 2026

Price Distribution

Price distribution over 83 days • 1 price levels

Days at Price
83 days 0 21 42 62 83 £495 Days at Price

Price Analysis

Most common price: £495 (83 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 83 days

Description

This study covers the latent demand outlook for benzodiazepine drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for benzodiazepine drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of benzodiazepine drugs as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Allergan, Apotex, Aurobindo Pharma, Bausch Health Companies, Cipla, Dr. Reddy's Laboratories, Endo International, F. Hoffmann-La Roche, H. Lundbeck, Lupin Pharmaceuticals, Mayne Pharma Group, Merck & Company, Mylan, N.V., Novartis, Otsuka Pharmaceutical Company, Pfizer, Sanofi, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, and Torrent Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
07 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Benzodiazepine Drugs in the United States
99% match

The 2023-2028 Outlook for Benzodiazepine Drugs in the United States

£520.00 05 Sep 2026
The 2023-2028 Outlook for Benzodiazepine Drugs in India
99% match

The 2023-2028 Outlook for Benzodiazepine Drugs in India

£515.00 04 Sep 2026
The 2025-2030 World Outlook for Benzodiazepine Drugs
99% match

The 2025-2030 World Outlook for Benzodiazepine Drugs

£790.00 02 Sep 2026
The 2023-2028 Outlook for Benzodiazepine Drugs for US Zip Codes
99% match

The 2023-2028 Outlook for Benzodiazepine Drugs for US Zip Codes

£490.00 05 Sep 2026
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
97% match

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan

£595.00 05 Sep 2026
The 2016 Report on Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives: World Market Segmentation by City
96% match

The 2016 Report on Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives: World Market Segmentation by City

£995.00 22 Aug 2026
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
96% match

The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States

£595.00 10 Jul 2026
The 2013-2018 Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines in India
96% match

The 2013-2018 Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines in India

£495.00 13 Aug 2026
The 2021-2026 World Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines
96% match

The 2021-2026 World Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines

Price unavailable
The 2016-2021 Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines in Greater China
95% match

The 2016-2021 Outlook for Non-Prescription Anxiolytic, Hypnotic, and Sleep-Inducing Sedatives Excluding Antihistamines in Greater China

£595.00 20 Jul 2026
Simultaneous Estimation of Benzodiazepines and Antidepressants: Optimization of SPE Protocol for single step and sequential elution followed by their HPLC estimation
95% match

Simultaneous Estimation of Benzodiazepines and Antidepressants: Optimization of SPE Protocol for single step and sequential elution followed by their HPLC estimation

LAP Lambert Academic Publishing

£62.00 11 Jul 2026
BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)
95% match

BENZODIAZEPINE: Abuse & Therapeutic Uses, Pharmacology & Health Effects (Pharmacology - Research, Safety Testing and Regulation: Substance Abuse Assessment, Interventions and Treatment)

£142.99 13 Jul 2026
The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
95% match

The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States

£520.00 23 Aug 2026
The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States
95% match

The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
95% match

The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States

£520.00 21 Aug 2026
Benzodiazepines II: A Handbook. Basic Data, Analytical Methods, Pharmacokinetics, and Comprehensive Literature
94% match

Benzodiazepines II: A Handbook. Basic Data, Analytical Methods, Pharmacokinetics, and Comprehensive Literature

Springer

£78.84 18 Jul 2026
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
94% match

The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States

£520.00 23 Aug 2026
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
94% match

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

£885.00 19 Aug 2026
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
94% match

The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States

£520.00 25 Aug 2026
Sleep, Benzodiazepines and Performance: Experimental Methodologies and Research Prospects: 1 (Psychopharmacology Series, 1)
94% match

Sleep, Benzodiazepines and Performance: Experimental Methodologies and Research Prospects: 1 (Psychopharmacology Series, 1)

Springer

£77.21 14 Jul 2026
The 2023-2028 Outlook for Insomnia Drugs for US Zip Codes
94% match

The 2023-2028 Outlook for Insomnia Drugs for US Zip Codes

£490.00 15 Aug 2026
The 2023-2028 Outlook for Over-the-Counter Medicinal Sleep Aids for US Zip Codes
94% match

The 2023-2028 Outlook for Over-the-Counter Medicinal Sleep Aids for US Zip Codes

£490.00 20 Aug 2026
Benzodiazepines and GHB: Detection and Pharmacology (Forensic Science and Medicine)
94% match

Benzodiazepines and GHB: Detection and Pharmacology (Forensic Science and Medicine)

Humana

£80.66 10 Jul 2026
The 2016-2021 Outlook for Biosimilars in Asia & the Middle East
94% match

The 2016-2021 Outlook for Biosimilars in Asia & the Middle East

£425.00 02 Sep 2026